Lawrence Whaley MD in Burleson, Texas

Home Texas Burleson

Lawrence Whaley MD has Emergency Medicine as his primary medical specialty. Their primary office is: 671 Ne Alsbury Blvd in Burleson, Texas. They attended University Of Texas Medical School At Houston and graduated in 1990 (around 34 years of experience). They are not listed as doing telehealth appointments, but this may have changed. It can't hurt to call and check. If anything it may encourage them to make them available if they are not currently.

Lawrence A Whaley MD Office Phone and Directions

Lawrence Whaley MD
671 Ne Alsbury Blvd
Burleson, Texas 76028
817-420-6463

Patient Ratings
Please rate your experience with Lawrence Whaley MD below to help others make a more informed decision. Thanks!

Current Rating: Loading...

Phone: 817-420-6463

Enter a starting address:

Healthcare Info for Lawrence Whaley MD

Medical School: University Of Texas Medical School At Houston
Graduation Year: 1990
The Primary Medical Specialty for Lawrence Whaley MD is listed as: Emergency Medicine
Credentials: MD
Additional Credentials:
Approximate Years of Experience: 34
PAC (PECOS ID)#: 8325931876
NPI #: 1821006552
NPI Created On: 08/05/2006
NPI Last Updated Listed as: 09/03/2018
Primary Taxonomy Code: 207R00000X
License Number:
K2627
Listed Gender: Male

Insurance, Services, Charges

Forms of insurance accepted by include, but are not limited to:

Humana
Blue Cross Blue Shield
Medicare

They are listed as accepting new patients.

Languages spoken by staff include: English.

Services and Procedures include:

Established patient office or other outpatient, visit typically 25 minutes

Open Payments Data. This can include items to test (Durable Medical Equipment (DME)), Biological, Drug Samples, etc. This data must be reported to CMS.

Payments Total: $15

Number of Payments:: 1

Form of Payment: In-kind items and services

Record ID:: 796246043

Being Disputed:: No

Product Related: Yes

Drug or Biological: Drug

Product Category #1: NEUROSCIENCE

Name of Drug #1: UBRELVY

Open Associated Drug #1: 0023-6501-10